Asalyxa

0 followers


Asalyxa bio is a novel biotech innate immune system targeting platform looking to regulate immune system response to prevent severe reactions through the power of immunotherapy.

Industries

Employees

11-50

Links

Org chart

Marc Appel
Founder & CEO

Marc Appel

Collapse
Lola Eniola-Adefeso
CSO & Founder
Bruce Auerbach
Head, Preclinical Development
Bill Miller
Senior Chemistry Advisor
Ken Olivier
Head, Toxicology
Bruce Weaver
Head, CMC
Garin M.
General Counsel